Healthtech Investors & VC Firms in Norway

37 firms in this list, with a median first check of $1M. 13 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
Techstars 5 people · Follows rounds	Boulder	US	Pre-Seed–Series A	$220K	+ Add to CRM
New Enterprise Associates (NEA) 71 people · Leads rounds	Menlo Park	US	Seed–Late Stage	$200K – $40M	+ Add to CRM
Northzone 46 people · Leads rounds	London	GB	Seed–Growth	$1M – $50M	+ Add to CRM
BaltCap 20 people	Tallinn	EE	Series B–Growth	$5.4M – $21.6M	+ Add to CRM
Procuritas 32 people · Leads rounds	Stockholm	SE	Growth	—	+ Add to CRM
Norrsken VC 21 people · Follows rounds	Stockholm	SE	Seed–Growth	$1.1M – $3.2M	+ Add to CRM
Unruly Capital 3 people	London	GB	Pre-Seed–Series A	—	+ Add to CRM
HealthCap 30 people	Stockholm	SE	Seed–Growth	—	+ Add to CRM
Inventure 14 people · Leads rounds	Helsinki	FI	Pre-Seed–Series A	$330K – $5.5M	+ Add to CRM
2050 29 people · Leads rounds	Paris	FR	Seed–Late Stage	—	+ Add to CRM
Alliance VC 9 people · Leads rounds	Oslo	NO	Pre-Seed–Series B	—	+ Add to CRM
Voima Ventures 12 people · Leads rounds	Helsinki	FI	Pre-Seed–Series B	$216K – $3.2M	+ Add to CRM
ACME Capital 12 people · Follows rounds	San Francisco	US	Pre-Seed–Growth	—	+ Add to CRM
Sarsia Management AS 13 people · Leads rounds	Bergen	NO	Seed–Series A	$190K – $475K	+ Add to CRM
500 Startups 8 people · Leads rounds	San Francisco	US	Pre-Seed–Late Stage	$10K – $250K	+ Add to CRM
People Ventures 12 people	Taastrup	DK	Pre-Seed–Series A	$270K – $2.2M	+ Add to CRM
Sandwater 12 people · Leads rounds	Oslo	NO	Seed–Series B	$2.2M – $11M	+ Add to CRM
Vesper Infrastructure Partners 16 people	London	GB	Growth–Late Stage	—	+ Add to CRM
EIR Ventures 10 people · Leads rounds	Stockholm	SE	Seed–Growth	—	+ Add to CRM
Nordic Science Investments 8 people · Leads rounds	Helsinki	FI	Pre-Seed–Series B	$55K – $3.9M	+ Add to CRM
Laerdal Million Lives Fund 9 people	San Francisco	US	Series A–Series B	$1M – $5M	+ Add to CRM
Viola Credit 12 people · Follows rounds	London	GB	Pre-Seed–Late Stage	$2M – $50M	+ Add to CRM
Aescap Life Sciences 14 people	Amsterdam	NL	Seed–Growth	—	+ Add to CRM
Eurazeo 12 people	Paris	FR	Series A–Late Stage	—	+ Add to CRM